» Articles » PMID: 31282537

Impact of Hypoxia on DNA Repair and Genome Integrity

Overview
Journal Mutagenesis
Date 2019 Jul 9
PMID 31282537
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

Hypoxia is a hallmark of the tumour microenvironment with profound effects on tumour biology, influencing cancer progression, the development of metastasis and patient outcome. Hypoxia also contributes to genomic instability and mutation frequency by inhibiting DNA repair pathways. This review summarises the diverse mechanisms by which hypoxia affects DNA repair, including suppression of homology-directed repair, mismatch repair and base excision repair. We also discuss the effects of hypoxia mimetics and agents that induce hypoxia on DNA repair, and we highlight areas of potential clinical relevance as well as future directions.

Citing Articles

Proteomic Analysis of Biomarkers Predicting Treatment Response in Patients with Head and Neck Cancers.

Zebene E, Lombardi R, Pucci B, Medhin H, Seife E, Di Gennaro E Int J Mol Sci. 2024; 25(23).

PMID: 39684225 PMC: 11641594. DOI: 10.3390/ijms252312513.


DNA damage response inhibitors in cancer therapy: lessons from the past, current status and future implications.

Drew Y, Zenke F, Curtin N Nat Rev Drug Discov. 2024; 24(1):19-39.

PMID: 39533099 DOI: 10.1038/s41573-024-01060-w.


ECM Proteins Nidogen-1 and Decorin Restore Functionality of Human Islets of Langerhans upon Hypoxic Conditions.

Jeyagaran A, Urbanczyk M, Carvajal-Berrio D, Baldissera T, Kaiser P, Kuhlburger L Adv Healthc Mater. 2024; 14(2):e2403017.

PMID: 39511898 PMC: 11730087. DOI: 10.1002/adhm.202403017.


Tricarboxylic Acid Cycle Relationships with Non-Metabolic Processes: A Short Story with DNA Repair and Its Consequences on Cancer Therapy Resistance.

Alvarez-Gonzalez E, Sierra L Int J Mol Sci. 2024; 25(16).

PMID: 39201738 PMC: 11355010. DOI: 10.3390/ijms25169054.


Non-hypermutator cancers access driver mutations through reversals in germline mutational bias.

Tuffaha M, Castellano D, Serrano Colome C, Gutenkunst R, Wahl L bioRxiv. 2024; .

PMID: 38746331 PMC: 11092619. DOI: 10.1101/2024.04.30.591900.


References
1.
Lu Y, Chu A, Turker M, Glazer P . Hypoxia-induced epigenetic regulation and silencing of the BRCA1 promoter. Mol Cell Biol. 2011; 31(16):3339-50. PMC: 3147797. DOI: 10.1128/MCB.01121-10. View

2.
Le D, Uram J, Wang H, Bartlett B, Kemberling H, Eyring A . PD-1 Blockade in Tumors with Mismatch-Repair Deficiency. N Engl J Med. 2015; 372(26):2509-20. PMC: 4481136. DOI: 10.1056/NEJMoa1500596. View

3.
Rockwell S, Dobrucki I, Kim E, Marrison S, Vu V . Hypoxia and radiation therapy: past history, ongoing research, and future promise. Curr Mol Med. 2009; 9(4):442-58. PMC: 2752413. DOI: 10.2174/156652409788167087. View

4.
Vaupel P, Mayer A . Hypoxia in cancer: significance and impact on clinical outcome. Cancer Metastasis Rev. 2007; 26(2):225-39. DOI: 10.1007/s10555-007-9055-1. View

5.
Dudas J, Schartinger V, Romani A, Schweigl G, Kordsmeyer K, Marta P . Cell cycle association and hypoxia regulation of excision repair cross complementation group 1 protein (ERCC1) in tumor cells of head and neck cancer. Tumour Biol. 2014; 35(8):7807-19. PMC: 4158184. DOI: 10.1007/s13277-014-2001-2. View